↓ Skip to main content

A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients

Overview of attention for article published in BMC Cancer, October 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
60 Mendeley